How can someone bleed when their platelet count is normal?

Platelets can be normal in number yet unable to adhere, aggregate, or release their granules properly. Such functional defects impair the formation of the platelet plug and can cause bleeding that a platelet count alone will not reveal.

What is light transmission aggregometry?

It is the long-standing reference test for platelet function. Platelets in plasma are stimulated with agonists, and the instrument measures how much light passes through as the platelets clump together, indicating how well they aggregate.

Platelet Function Disorders and Platelet-Function Testing

Platelet function disorders are conditions in which platelets are present in adequate numbers but fail to perform one or more of the steps of primary hemostasis, such as adhesion, activation, aggregation, or granule secretion. Because the platelet count is normal, these defects are detected not by counting but by platelet-function testing, of which light transmission aggregometry is the long-standing reference method.

Definition

A platelet function disorder is a qualitative defect of platelet hemostatic function (adhesion, activation, aggregation, or secretion) occurring with a normal or near-normal platelet count; platelet-function testing comprises the laboratory assays, notably light transmission aggregometry, used to detect and characterize such defects.

Scope

The entry covers the categories of inherited and acquired platelet function defects, the components of platelet function they affect, and the laboratory methods used to investigate them, including aggregometry and complementary assays. It is a methodological and reference topic within hematopathology and does not provide diagnostic cut-offs or treatment guidance for individual patients.

Core questions

How can platelets cause bleeding when the platelet count is normal?
Which step of platelet function is impaired in a given disorder?
What does light transmission aggregometry measure and how is it standardized?
How are inherited platelet function disorders distinguished from acquired (often drug-related) ones?

Key concepts

Primary hemostasis and the platelet plug
Adhesion, activation, aggregation, and secretion
Inherited platelet function disorders (e.g., Glanzmann thrombasthenia, Bernard-Soulier syndrome)
Acquired and drug-induced platelet dysfunction
Light transmission aggregometry
Standardization and pre-analytical variables in platelet-function testing

Mechanisms

Platelets contribute to hemostasis by adhering to exposed subendothelium, activating and changing shape, secreting the contents of their granules, and aggregating through fibrinogen bridging at the GPIIb/IIIa receptor. Inherited disorders disrupt specific steps: defects of the GPIIb/IIIa receptor impair aggregation (Glanzmann thrombasthenia), defects of the GPIb-IX-V complex impair adhesion (Bernard-Soulier syndrome), and storage-pool and secretion defects impair granule release. Acquired dysfunction is common, particularly from antiplatelet drugs, uremia, and myeloproliferative states. Light transmission aggregometry measures the increase in light transmission as platelets in plasma aggregate after stimulation with agonists, and its interpretation depends on standardized pre-analytical and analytical conditions (Cattaneo et al., 2013; Harrison et al., 2011).

Clinical relevance

Identifying and classifying platelet function defects informs the laboratory evaluation of mucocutaneous bleeding that occurs despite a normal platelet count, and standardized testing supports comparable results across laboratories (Gomez et al., 2021; Cattaneo et al., 2013). This entry is educational and does not provide diagnostic thresholds or management recommendations for individual patients.

Epidemiology

Acquired platelet dysfunction, especially from antiplatelet medication, is far more common than the inherited disorders, which are individually rare; the heritable defects nonetheless form an important group in the investigation of lifelong bleeding tendencies (Gomez et al., 2021).

History

The introduction of turbidimetric (light transmission) platelet aggregometry by Born and others in the early 1960s made platelet function measurable in the laboratory and remains the reference technique. Subsequent decades defined the molecular basis of the major inherited disorders and produced consensus efforts to standardize aggregometry and the broader diagnostic workup of platelet function defects (Cattaneo et al., 2013; Harrison et al., 2011; Gomez et al., 2021).

Debates

How standardized is platelet-function testing across laboratories?: Light transmission aggregometry has historically varied in agonists, concentrations, and pre-analytical handling between laboratories, prompting consensus recommendations to improve comparability and interpretation of results.

Seminal works

harrison-2011
cattaneo-2013
gomez-2021

Frequently asked questions

How can someone bleed when their platelet count is normal?: Platelets can be normal in number yet unable to adhere, aggregate, or release their granules properly. Such functional defects impair the formation of the platelet plug and can cause bleeding that a platelet count alone will not reveal.
What is light transmission aggregometry?: It is the long-standing reference test for platelet function. Platelets in plasma are stimulated with agonists, and the instrument measures how much light passes through as the platelets clump together, indicating how well they aggregate.